BillionToOne, Inc. reported first quarter ended March 31, 2026 results: revenue $108.4 million, net income $18.0 million, or $0.34 per diluted share, EPS $0.34 per diluted share. Guidance raised.
“to all, today reported its financial results for the first quarter ended March 31, 2026 and raised guidance for full year 2026. Financial Highlights: ● Total revenue of $108.4 million in the first quarter of 2026, compared to $59.0 million in the first quarter of 2025, an increase of 84%. ● Prenatal clinical testing revenue was $96.5 million in the first”
Earnings Releases
BillionToOne, Inc. updated its the year ended December 31, 2025 guidance (raised).
“On March 4, 2026 , BillionToOne, Inc. (the “Company”) issued a press release announcing financial results for the quarter and year ended December 31, 2025.”
Earnings Releases
BillionToOne, Inc. updated its the fourth quarter ended December 31, 2025 guidance (raised).
“On March 4, 2026 , BillionToOne, Inc. (the “Company”) issued a press release announcing financial results for the quarter and year ended December 31, 2025.”
Governance Changes
BillionToOne, Inc.: Amended and restated bylaws became effective upon IPO closing (effective 2025-11-07).
“and its amended and restated bylaws (the “Bylaws”) became effective, in connection with the closing of the initial public offering”
Governance Changes
BillionToOne, Inc.: Amended and restated certificate of incorporation became effective upon IPO closing (effective 2025-11-07).
“On November 7, 2025, BillionToOne, Inc. (the “Company”) filed its amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.